MD Anderson Cancer Center Archives

Could nonthermal tumor ablation replace surgery for low-risk thyroid cancer? Pulse Biosciences launches feasibility study

By Pallavi Madhiraju on March 13, 2026 Medical Devices & Diagnostics

Pulse Biosciences begins human study of nsPFA thyroid cancer treatment. Discover what this trial could mean for minimally invasive oncology.

Could Io Therapeutics’ IRX4204 reshape the science of breast cancer prevention?

By Soujanya Ravi on March 11, 2026 Medical Devices & Diagnostics

Could IRX4204 help prevent triple-negative breast cancer? Discover what new RXR agonist research could mean for the future of breast cancer prevention.

Proton therapy delivers survival gain in head and neck cancer: Could this Lancet trial shift payer and policy resistance?

By Pallavi Madhiraju on December 13, 2025 Pharma & Biotech

A new phase III clinical trial published in The Lancet has shown that proton therapy significantly improves overall survival and reduces treatment-related toxicities in patients with oropharyngeal cancers compared to traditional photon-based radiation. Conducted across 21 U.S. institutions and led by researchers at the University of Texas MD Anderson Cancer Center, the study is the […]